UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1

Indian journal of surgical oncology, 2024-09, Vol.15 (3), p.484-488

2024

Volltextzugriff (PDF)

Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients

Indian journal of surgical oncology, 2024-09, Vol.15 (3), p.489-494

2024

Volltextzugriff (PDF)

Are radiologists ready to evaluate true response to immunotherapy?

Insights into imaging, 2021-02, Vol.12 (1), p.29-29, Article 29

2021

Volltextzugriff (PDF)

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

European journal of breast health, 2023-04, Vol.19 (2), p.128-133

2023

Volltextzugriff (PDF)

Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome

Urologia internationalis, 2013-01, Vol.90 (4), p.435-438

2013

Volltextzugriff (PDF)

Metastases to the Stomach: Clinicopathologic Features of Metastases Mimicking Gastric Primaries

Turk patoloji dergisi, 2021, Vol.37 (3), p.203

2021

Volltextzugriff (PDF)

“Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic

Chemotherapy (Basel), 2020, Vol.65 (5-6), p.141-146

2020

Volltextzugriff (PDF)

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21149-e21149

2021

Volltextzugriff (PDF)

Rare pancreas tumor mimicking adenocarcinoma: Extramedullary plasmacytoma

World journal of gastrointestinal endoscopy, 2014-03, Vol.6 (3), p.99-100

2014

Volltextzugriff (PDF)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13031-e13031

2022

Volltextzugriff (PDF)

Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e14002-e14002

2022

Volltextzugriff (PDF)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S587-S591

2023

Volltextzugriff (PDF)

Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process

Oncology, 2023-04, Vol.101 (4), p.262-269

2023

Volltextzugriff (PDF)

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Journal of oncological science, 2016-04, Vol.2 (1), p.7-11

2016

Volltextzugriff (PDF)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.289-289

2021

Volltextzugriff (PDF)

Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177Lu-PSMA With No Adrenal Insufficiency

Clinical nuclear medicine, 2024-01, Vol.49 (1), p.e8-e9

2024

Volltextzugriff (PDF)

Factors affecting recurrence and survival in Stage IIA colon cancer patients

Oncology, 2024-07

2024

Volltextzugriff (PDF)

Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST

Journal of cancer research and therapeutics, 2024-01, Vol.20 (1), p.156-162

2024

Volltextzugriff (PDF)

Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal Insufficiency

Clinical nuclear medicine, 2024-01, Vol.49 (1), p.e8

2024

Volltextzugriff (PDF)

Alveolar echinococcosis localized in the liver, lung and brain

Chinese medical journal, 2008-01, Vol.121 (1), p.90-92

2008

Volltextzugriff (PDF)

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data

Dermatologic therapy, 2021-11, Vol.34 (6), p.e15122-n/a

2021

Volltextzugriff (PDF)

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Journal of cancer research and therapeutics, 2023-10, Vol.19 (7), p.1945-1949

2023

Volltextzugriff (PDF)

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Journal of gastrointestinal cancer, 2022-12, Vol.53 (4), p.870-879

2022

Volltextzugriff (PDF)

The Significance of Preoperative Computed Tomography Features in the Prediction of Overall Survival in Gastric Cancer: A Retrospective Analysis

Şişli Etfal Hastanesi tıp bülteni, 2023-01, Vol.57 (2), p.195-203

Kizildag Yirgin, Inci

2023

Volltextzugriff (PDF)

Predictors of the acquisition of T790M mutation in EGFR mutant metastatic lung cancer patients who were treated with EGFR inhibitors

Eurasian Journal of Pulmonology, 2023-01

Dogan, Izzet

2023

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(72)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1

Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients

Are radiologists ready to evaluate true response to immunotherapy?

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome

Metastases to the Stomach: Clinicopathologic Features of Metastases Mimicking Gastric Primaries

“Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Rare pancreas tumor mimicking adenocarcinoma: Extramedullary plasmacytoma

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177Lu-PSMA With No Adrenal Insufficiency

Factors affecting recurrence and survival in Stage IIA colon cancer patients

Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST

Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177 Lu-PSMA With No Adrenal Insufficiency

Alveolar echinococcosis localized in the liver, lung and brain

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

The Significance of Preoperative Computed Tomography Features in the Prediction of Overall Survival in Gastric Cancer: A Retrospective Analysis

Predictors of the acquisition of T790M mutation in EGFR mutant metastatic lung cancer patients who were treated with EGFR inhibitors

Suchergebnisse filtern